Cecilie Abildgaard

736 total citations
17 papers, 575 citations indexed

About

Cecilie Abildgaard is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cecilie Abildgaard has authored 17 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Cecilie Abildgaard's work include Cancer-related molecular mechanisms research (5 papers), Melanoma and MAPK Pathways (4 papers) and Cancer Research and Treatments (3 papers). Cecilie Abildgaard is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Melanoma and MAPK Pathways (4 papers) and Cancer Research and Treatments (3 papers). Cecilie Abildgaard collaborates with scholars based in Denmark, Brazil and Spain. Cecilie Abildgaard's co-authors include Per Guldberg, Christina Dahl, Sílvia Regina Rogatto, Luísa Matos do Canto, Ingolf F. Nes, Morten Skaugen, Karina Dahl Steffensen, Per Bo Jensen, Arnaldur Hall and Jiří Bártek and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Investigative Dermatology.

In The Last Decade

Cecilie Abildgaard

17 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilie Abildgaard Denmark 12 411 202 140 71 47 17 575
Marta Di Martile Italy 15 455 1.1× 117 0.6× 127 0.9× 103 1.5× 51 1.1× 35 649
Ariadna Sarrats Spain 11 493 1.2× 137 0.7× 113 0.8× 151 2.1× 57 1.2× 14 679
Bu‐Nam Jeon South Korea 14 453 1.1× 125 0.6× 125 0.9× 111 1.6× 30 0.6× 27 639
Anthony McCabe Ireland 8 275 0.7× 95 0.5× 213 1.5× 41 0.6× 29 0.6× 10 547
Yudong Wang China 13 358 0.9× 122 0.6× 70 0.5× 98 1.4× 15 0.3× 28 563
Xiaona Fang China 13 278 0.7× 113 0.6× 160 1.1× 62 0.9× 43 0.9× 20 498
Francesco Gatto Sweden 15 678 1.6× 214 1.1× 120 0.9× 40 0.6× 82 1.7× 35 879
Shelley J. Edmunds New Zealand 13 486 1.2× 216 1.1× 176 1.3× 67 0.9× 57 1.2× 15 759
Luís Sánchez‐del‐Campo Spain 17 594 1.4× 150 0.7× 169 1.2× 141 2.0× 147 3.1× 29 897
Alejandra Tavera-Tapia Spain 5 490 1.2× 378 1.9× 259 1.9× 34 0.5× 24 0.5× 10 691

Countries citing papers authored by Cecilie Abildgaard

Since Specialization
Citations

This map shows the geographic impact of Cecilie Abildgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilie Abildgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilie Abildgaard more than expected).

Fields of papers citing papers by Cecilie Abildgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilie Abildgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilie Abildgaard. The network helps show where Cecilie Abildgaard may publish in the future.

Co-authorship network of co-authors of Cecilie Abildgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilie Abildgaard. A scholar is included among the top collaborators of Cecilie Abildgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilie Abildgaard. Cecilie Abildgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Long, Georgina V., Robert I. Haddad, Caroline Robert, et al.. (2024). A randomized phase 2 trial of the IO102-IO103 (IDO and PD-L1) cancer vaccine plus pembrolizumab as neoadjuvant/adjuvant treatment of patients with solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2701–TPS2701. 2 indexed citations
2.
Riess, Jonathan W., James Spicer, Tanguy Y. Seiwert, et al.. (2024). 756 A phase 2 trial of the IO102-IO103 cancer vaccine plus pembrolizumab: results from the first-line (1L) cohort of PD-L1 high metastatic non-small cell lung cancer (NSCLC). Regular and Young Investigator Award Abstracts. A860–A860. 1 indexed citations
3.
Jensen, Lars Henrik, Sílvia Regina Rogatto, Jan Lindebjerg, et al.. (2023). Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study. Journal of Experimental & Clinical Cancer Research. 42(1). 115–115. 35 indexed citations
4.
Carvalho, Robson Francisco, Luísa Matos do Canto, Cecilie Abildgaard, et al.. (2022). Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer. Cell Communication and Signaling. 20(1). 176–176. 33 indexed citations
5.
Abildgaard, Cecilie, Luísa Matos do Canto, Cláudia Aparecida Rainho, et al.. (2022). The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms. Cancers. 14(7). 1664–1664. 11 indexed citations
6.
Abildgaard, Cecilie, Salvatore Rizza, Helle Christiansen, et al.. (2021). Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma. Scientific Reports. 11(1). 4390–4390. 14 indexed citations
7.
Jensen, Lars Henrik, Anders Jakobsen, Birgitte Mayland Havelund, et al.. (2021). Functional precision medicine in colorectal cancer based on patient-derived tumoroids and in-vitro sensitivity drug testing.. Journal of Clinical Oncology. 39(15_suppl). e15567–e15567. 1 indexed citations
8.
Abildgaard, Cecilie, Luísa Matos do Canto, Karina Dahl Steffensen, & Sílvia Regina Rogatto. (2020). Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer. Frontiers in Oncology. 9. 1549–1549. 40 indexed citations
9.
Abildgaard, Cecilie, et al.. (2020). The Interplay between Long Noncoding RNAs and Proteins of the Epigenetic Machinery in Ovarian Cancer. Cancers. 12(9). 2701–2701. 8 indexed citations
10.
Dahl, Christina, Per Guldberg, & Cecilie Abildgaard. (2019). Evaluating the Role of RARβ Signaling on Cellular Metabolism in Melanoma Using the Seahorse XF Analyzer. Methods in molecular biology. 2019. 171–180. 4 indexed citations
11.
Barros‐Filho, Mateus Camargo, Mariana Bisarro dos Reis, Fábio Albuquerque Marchi, et al.. (2018). Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma. Clinical Epigenetics. 10(1). 144–144. 30 indexed citations
12.
Abildgaard, Cecilie, et al.. (2017). Inhibition of retinoic acid receptor β signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells. Oncotarget. 8(48). 84210–84223. 12 indexed citations
13.
Abildgaard, Cecilie & Per Guldberg. (2015). Molecular drivers of cellular metabolic reprogramming in melanoma. Trends in Molecular Medicine. 21(3). 164–171. 100 indexed citations
14.
Dahl, Christina, Cecilie Abildgaard, Rikke Riber‐Hansen, et al.. (2014). KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma. Journal of Investigative Dermatology. 135(2). 516–524. 34 indexed citations
15.
Abildgaard, Cecilie, Christina Dahl, A. Basse, Tao Ma, & Per Guldberg. (2014). Bioenergetic modulation with dichloroacetate reduces the growth of melanoma cells and potentiates their response to BRAFV600E inhibition. Journal of Translational Medicine. 12(1). 247–247. 40 indexed citations
16.
Hall, Arnaldur, Kathrine Damm Meyle, Martin Klíma, et al.. (2013). Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene. Oncotarget. 4(4). 584–599. 154 indexed citations
17.
Skaugen, Morten, Cecilie Abildgaard, & Ingolf F. Nes. (1997). Organization and expression of a gene cluster involved in the biosynthesis of the lantibiotic lactocin S. Molecular and General Genetics MGG. 253(6). 674–686. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Di Martile Breakdown of academic impact, for papers by Ariadna Sarrats Breakdown of academic impact, for papers by Bu‐Nam Jeon Breakdown of academic impact, for papers by Anthony McCabe Breakdown of academic impact, for papers by Yudong Wang Breakdown of academic impact, for papers by Xiaona Fang Breakdown of academic impact, for papers by Francesco Gatto Breakdown of academic impact, for papers by Shelley J. Edmunds Breakdown of academic impact, for papers by Luís Sánchez‐del‐Campo Breakdown of academic impact, for papers by Alejandra Tavera-Tapia
Rankless by CCL
2026